// App-Quantinova.ai

PB1750 : COST-EFFECTIVENESS OF RUXOLITINIB FOR PATIENTS WITH MYELOFIBROSIS: A REVIEW OF THE LITERATURE

Researchers

Presenter

  • Gizem Karakuleli

Principal Investigators

  • Leela Barham

Medical Centers

  • Scientific Education Support,Richmond,United Kingdom

  • Learna Ltd in partnership with the University of South Wales,London,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelofibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Ruxolitinib phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved